Advocacy Actions

2023-05-19 > Beijing, National

Call for Comments: NIFDC notice on Drafting Instruction for Technical Guidelines for Filling in and Submitting Cosmetic Ingredient Safety Information

On 19th May, the cosmetics working group submitted the feedback on Drafting Instruction for Technical Guidelines for Filling in and Submitting Cosmetic Ingredient Safety Information (Draft for Comments) which has been released by NIFDC.

Read more
2023-04-13 > Beijing, Shanghai

The European Chamber Co-host seminar: The 5th Jing'an District Cosmetics Salon

The European Chamber Cosmetics Working Group co-cost government seminar- the 5th Jing'an District Cosmetics Salon themed Government Enterprise Interaction Helps High Quality Industrial Development was held on April 13, 2023. Zhang Jun, Deputy District Mayor of Jing'an District; Zhao Yanjun, Deputy Commissioner of Shanghai Medical Products Administration and other officials and experts attended the meeting. During the penal discussion session, officials and company representatives exchanged ideas and recommendations on key industrial topics.

Read more
2023-03-31 > Beijing, Shanghai, National

Call for Comments: NIFDC notice on Research and Technical Guideline for Anti-freckle and whiting cosmetics products and ingredient

on 31st March, the cosmetics working group submitted the consolidated comments on Research and Technical Guideline for Anti-freckle and whiting cosmetics products and ingredient published by NIFDC.

Read more
2023-03-27 > Beijing, Shanghai

Meeting with Shanghai Medical Products Administration and European Cosmetics Association

On 27th March 2023, the cosmetics working group representatives attended the meeting with Shanghai Medical Products Administration and European Cosmetics Association.

Read more
2023-03-13 > National

Advocacy letter to National Medical Product Administration on acceptance of ISO standard of microbiology

On 13th March, the cosmetics working group submitted the advocacy letter on acceptance of ISO standard of microbiology to NMPA.

Read more
2023-01-06 > Beijing, National

Comment to SAMR on Notice of Public Consultation on the Guidelines for Enforcement of Absolutist Terms in Advertising (Draft for Comments)

The Agriculture, Food and Beverage Working Group, Food for Special Medical Purpose, Dairy Industry and Pediatric Nutrition Sub-working Groups, Compliance and Business Ethics Working Group, Cosmetics Working Group, Fashion and Leather Desk submitted collated comments to State Administration for Marketing Regulation on The Agriculture, Food and Beverage Working Group, Food for Special Medical Purpose, Dairy Industry and Pediatric Nutrition Sub-working Groups submitted collated comments to State Administration for Marketing Regulation on Regulations (SAMR) on the Supervision and Management of Enterprises' Implementation of the Main Responsibility for Food Safety (Draft for Comments).

Read more
2021-12-17 > Beijing

Lobby Letter to NMPA on Material Safety Information Submission, Efficacy Evaluation, Transition Period and Labelling

On December 17th, Cosmetics Working Group sent a lobby Letter to NMPA on Material Safety Information Submission, Efficacy Evaluation, Transition Period and Labelling.

Read more
2021-12-01 > Beijing

Meeting with Mr. Ramunas Freigofas, First Counsellor for Health and Food Safety of EU Delegation to China

European Chamber representatives from agriculture, EU affairs, food and beverage, cosmetics, healthcare equipment, pharmaceutical sectors, met with Mr. Ramunas Freigofas, First Counsellor for Health and Food Safety of EU Delegation to China to exchange work priorities of both sides and plan for further cooperation.

Read more
2021-10-20 > Beijing

Lobby Letter to NMPA on TOP 5 Core Topics

A lobby letter to NMPA on TOP 5 core topics European Chamber Cosmetics Working Group care the most.

Read more
2021-10-15 > Beijing

Call for Comments on Measures for the Management of Cosmetic Adverse Reaction Monitoring

Cosmetics Working Group sent Call for Comments on Measures for the Management of Cosmetic Adverse Reaction Monitoring.

Read more